Search For
48 result(s) for 'Breast cancer'
Current applications of tumor local ablation (TLA) combined with immune checkpoint inhibitors in breast cancer treatment
Open Access Review 12 Sep 2024
DOI: 10.20517/cdr.2024.77
Views: Downloads:
The role of circRNAs and miRNAs in drug resistance and targeted therapy responses in breast cancer
Open Access Review 19 Aug 2024
DOI: 10.20517/cdr.2024.62
Views: Downloads:
Mechanisms of action and resistance to anti-HER2 antibody-drug conjugates in breast cancer
Open Access Review 2 Jun 2024
DOI: 10.20517/cdr.2024.06
Views: Downloads:
The therapeutic potential of circular RNA in triple-negative breast cancer
Open Access Review 22 Apr 2024
Views: Downloads:
Immune checkpoint inhibitors in breast cancer: development, mechanisms of resistance and potential management strategies
Open Access Review 16 Nov 2023
DOI: 10.20517/cdr.2023.58
Views: Downloads:
Resistance of breast cancer cells to paclitaxel is associated with low expressions of miRNA-186 and miRNA-7
Open Access Original Article 31 Aug 2023
DOI: 10.20517/cdr.2023.19
Views: Downloads:
Harnessing the value of TCTP in breast cancer treatment resistance: an opportunity for personalized therapy
Open Access Review 12 Jul 2023
DOI: 10.20517/cdr.2023.21
Views: Downloads:
Targeting hormone-resistant breast cancer cells with docetaxel: a look inside the resistance
Open Access Original Article 6 Feb 2023
DOI: 10.20517/cdr.2022.96
Views: Downloads:
The change of paradigm in the treatment of HER2-positive breast cancer with the development of new generation antibody-drug conjugates
Open Access Opinion 11 Jan 2023
DOI: 10.20517/cdr.2022.52
Views: Downloads:
Concomitant medications and circulating tumor cells: friends or foes?
Open Access Commentary 3 Jan 2023
DOI: 10.20517/cdr.2022.68
Views: Downloads:
Association between genome-wide epigenetic and genetic alterations in breast cancer tissue and response to HER2-targeted therapies in HER2-positive breast cancer patients: new findings and a systematic review
Open Access Review 1 Nov 2022
DOI: 10.20517/cdr.2022.63
Views: Downloads:
Loss of HER2 in breast cancer: biological mechanisms and technical pitfalls
Open Access Perspective 19 Oct 2022
DOI: 10.20517/cdr.2022.55
Views: Downloads:
- 1
- 2
- 3
- 4